
Medikon India Private Limited
About Medikon India Private Limited
Data last updated:
Medikon India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 December 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21002DL2023PTC424510.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Rajat Bhatiani and Anuj Bhatiani.
Its last annual general meeting (AGM) was held on 05 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B – 32/B, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2024, the company reported a revenue of ₹98.65 Lakh. For the same year it recorded a net profit of ₹4 Lakh (net margin 4.1%) and EBITDA of ₹5.35 Lakh (EBITDA margin 5.4%).
As per MCA filings, the company has open charges of ₹29.37 Cr on record.
Company details
Contact details
Medikon India Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressB – 32/B, New Delhi, Delhi, India – 110019
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medikon India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medikon India Private Limited, buy the company report.
Financials of Medikon India Private Limited
FY 2024 filings availableMedikon India Private Limited reported revenue of ₹98.65 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹5.35 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹4 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | 5.4% |
| Net Profit Margin | 4.1% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Medikon India Private Limited, buy the company report.
Board of directors of Medikon India Private Limited
Medikon India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajat Bhatiani | Director | 28 Dec 2023 | 2 Years 10 Months | Current |
| Anuj Bhatiani Also directs: Arise Holding LLP, Surgikon India Private Limited, Vardan Eyecare Private Limited and 1 more | Director | 28 Dec 2023 | 2 Years 10 Months | Current |
Peer comparison
Medikon India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| N.E.W.S. Pharma Private Limited | ₹98.94 Lakh (FY 2022) | -9.0% | Panchkula, Haryana, India | |||
| Synthesis Pharmaceutical Private Limited | ₹98.67 Lakh (FY 2024) | 34.0% | Indore, Madhya Pradesh, India | |||
| Medikon India Private Limitedthis company | ₹98.65 Lakh (FY 2024) | ₹4 Lakh | 4.1% | New Delhi, Delhi, India | ||
| Morgan Drugs Private Limited | ₹98.64 Lakh (FY 2019) | 6.0% | Lakhisarai, Bihar, India | |||
| S.G.P.Exim Private Limited | ₹98.46 Lakh (FY 2025) | -4.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Medikon India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Mar 2025 | 101117232 | Hdfc Bank Limited | ₹20.1 Lakh | Open | |
| 28 Jan 2025 | 101046454 | Others | ₹29.17 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Medikon India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medikon India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medikon India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medikon India Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Anuj Bhatiani was appointed as Director on 28 Dec 2023.
Frequently asked questions
Medikon India is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 December 2023 (3+ years old) and is registered under CIN U21002DL2023PTC424510.
Medikon India has 2 current directors:
- Rajat Bhatiani - Director
- Anuj Bhatiani - Director
The latest financial statements of Medikon India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 05 December 2024. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Medikon India is U21002DL2023PTC424510. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medikon India was incorporated on 28 December 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medikon India by revenue are N.E.W.S. Pharma Private Limited, Synthesis Pharmaceutical Private Limited, Morgan Drugs Private Limited, S.G.P.Exim Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Anuj Bhatiani was appointed as Director on 28 Dec 2023. Rajat Bhatiani was appointed as Director on 28 Dec 2023.
The registered office of Medikon India is at B – 32B, New Delhi, Delhi, India – 110019.
Medikon India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Medikon India has open charges of ₹29.37 Cr and no satisfied charges on record as per latest MCA filings.
Medikon India can be reached at its registered office: B – 32B, New Delhi, Delhi, India – 110019.

